Table 1 Key data items and time-points
Key data entry time points | Data items collected |
|---|---|
Baseline: Demographics and disease characteristics at diagnosis | Date of birth, sex, genetic ethnic heritage, pregnancy status Height and weight Medical history, including current comorbidities, previous malignancies, ECOG performance status Family history of haematologic malignancy WHO classification disease stage Molecular and cytogenetic abnormalities – Those judged to be of most prognostic value for a given diagnosis Full blood count Other laboratory fields relevant to prognostic indices Quality of life (EQ-5D-5L)a Samples tissue banked, if applicable |
Therapy (Repeatable event to collect each line) | Planned therapy, including chemo-/immuno-/radiotherapy, haematopoietic stem cell transplantation (autologous/allogeneic), supportive care, participation in clinical trial (if applicable) Delivered therapy, including commencement date and any variations to planned therapy Response: Interim response and initial response |
Reviews (6 and 12 months and annually thereafter or as required) | Vital status, date and cause of death if applicable Relapse/progression, date of progression if appropriate Loss to follow-up, date of last contact |